Ribupatide
A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity
Fujian Shengdi Pharmaceutical Co · Phase 3 · Recruiting · Enrollment 140
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.